These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25740244)

  • 1. Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300.
    Uttarkar S; Dukare S; Bopp B; Goblirsch M; Jose J; Klempnauer KH
    Mol Cancer Ther; 2015 Jun; 14(6):1276-85. PubMed ID: 25740244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells.
    Uttarkar S; Piontek T; Dukare S; Schomburg C; Schlenke P; Berdel WE; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Mol Cancer Ther; 2016 Dec; 15(12):2905-2915. PubMed ID: 27707899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
    Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
    J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction.
    Jones M; Grosche P; Floersheimer A; André J; Gattlen R; Oser D; Tinchant J; Wille R; Chie-Leon B; Gerspacher M; Ertl P; Ostermann N; Altmann E; Manchado E; Vorherr T; Chène P
    Biochemistry; 2023 Apr; 62(7):1321-1329. PubMed ID: 36883372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression.
    Kasper LH; Fukuyama T; Lerach S; Chang Y; Xu W; Wu S; Boyd KL; Brindle PK
    PLoS One; 2013; 8(12):e82684. PubMed ID: 24340053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.
    Uttarkar S; Dassé E; Coulibaly A; Steinmann S; Jakobs A; Schomburg C; Trentmann A; Jose J; Schlenke P; Berdel WE; Schmidt TJ; Müller-Tidow C; Frampton J; Klempnauer KH
    Blood; 2016 Mar; 127(9):1173-82. PubMed ID: 26631113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Myb-p300 Interaction Is a Novel Molecular Pharmacologic Target.
    Liu X; Gold KA; Dmitrovsky E
    Mol Cancer Ther; 2015 Jun; 14(6):1273-5. PubMed ID: 25995438
    [No Abstract]   [Full Text] [Related]  

  • 8. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
    Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the transcription factor Myb by small-molecule inhibitors.
    Uttarkar S; Frampton J; Klempnauer KH
    Exp Hematol; 2017 Mar; 47():31-35. PubMed ID: 28017646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for cooperative regulation of KIX-mediated transcription pathways by the HTLV-1 HBZ activation domain.
    Yang K; Stanfield RL; Martinez-Yamout MA; Dyson HJ; Wilson IA; Wright PE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10040-10045. PubMed ID: 30232260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conserved patch of hydrophobic amino acids modulates Myb activity by mediating protein-protein interactions.
    Dukare S; Klempnauer KH
    Biochim Biophys Acta; 2016 Jul; 1859(7):914-21. PubMed ID: 27080133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis.
    Kasper LH; Boussouar F; Ney PA; Jackson CW; Rehg J; van Deursen JM; Brindle PK
    Nature; 2002 Oct; 419(6908):738-43. PubMed ID: 12384703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
    Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
    PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
    Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
    Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.
    Cook PR; Polakowski N; Lemasson I
    J Mol Biol; 2011 Jun; 409(3):384-98. PubMed ID: 21497608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Yusenko MV; Trentmann A; Casolari DA; Abdel Ghani L; Lenz M; Horn M; Dörner W; Klempnauer S; Mootz HD; Arteaga MF; Mikesch JH; D'Andrea RJ; Gonda TJ; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Oncogene; 2021 Jul; 40(29):4746-4758. PubMed ID: 33958723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
    Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
    Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of a helical peptide inhibitor targeting c-Myb-KIX interaction.
    Suetaka S; Oka Y; Kunihara T; Hayashi Y; Arai M
    Sci Rep; 2022 Jan; 12(1):816. PubMed ID: 35058484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.
    Nicot C; Mahieux R; Pise-Masison C; Brady J; Gessain A; Yamaoka S; Franchini G
    Mol Cell Biol; 2001 Nov; 21(21):7391-402. PubMed ID: 11585920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adaptor protein ARA55 and the nuclear kinase HIPK1 assist c-Myb in recruiting p300 to chromatin.
    Bengtsen M; Sørensen L; Aabel L; Ledsaak M; Matre V; Gabrielsen OS
    Biochim Biophys Acta Gene Regul Mech; 2017 Jul; 1860(7):751-760. PubMed ID: 28495617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.